FOCL
EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology. The UDS segment focuses on the development, marketing, manufacturing, and servicing of medical devices for the minimally invasive diagnosis or treatment of urological disorders, mainly urinary stones, and other clinical indications. The company was founded on December 3, 1979 and is headquartered in Vaulx-en-Velin, France.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q1 | -0.24 | $18M | -$4M |
| 2025 Q4 | -0.25 | $22M | -$4M |
| 2025 Q3 | -0.16 | $16M | — |
| 2025 Q2 | -0.17 | $18M | — |
| 2025 Q1 | -0.20 | $14M | -$7M |
| 2024 Q4 | -0.06 | $22M | — |
| 2024 Q2 | -0.18 | $17M | -$7M |
| 2024 Q1 | -0.13 | $16M | -$5M |